The company’s PhD research focused on using lasers for precise intracellular cargo delivery. However, conversations with 100+ industry experts revealed a more critical, and technically simpler, problem in cell therapy manufacturing: removing unwanted cells. This demonstrates the value of prioritizing market needs over scientific complexity.

Instead of pitching an idea upfront, the founders first conducted broad interviews, asking security leaders for their top 5 problems. Only after identifying a recurring pain that matched their thesis did they switch to phase two: presenting a specific solution to validate its acuity and demand.

The transition from academia to entrepreneurship is most successful when the focus shifts from pure science or technology to solving a tangible, pre-existing clinical problem. This ensures market interest, clinical adoption, and ultimately, patient impact from the outset.

A common pitfall for founders transitioning from a PhD is creating pitch decks that are essentially scientific presentations. Investors are less interested in how the technology works and more interested in the magnitude of the problem it solves and the market's demand for that solution. The 'what' and 'why' trump the 'how'.

Moving technology from academia to a startup requires a crucial mindset shift. The academic goal of publishing data must be replaced by the industry requirement of extensive validation. For Vivtex, this single piece of advice added years of work but was essential for creating a commercially viable platform.

Successful MedTech innovation starts by identifying a pressing, real-world clinical problem and then developing a solution. This 'problem-first' approach is more effective than creating a technology and searching for an application, a common pitfall for founders with academic backgrounds.

After years of licensing their technologies to other companies post-proof-of-concept, the academic co-founders started Medera to take direct ownership. They identified a critical need to merge their deep scientific understanding with the practical execution required to translate lab insights into patient therapies themselves.

Instead of searching for a market to serve, founders should solve a problem they personally experience. This "bottom-up" approach guarantees product-market fit for at least one person—the founder—providing a solid foundation to build upon and avoiding the common failure of abstract, top-down market analysis.

This reframes the fundamental goal of a startup away from a supply-side focus (building) to a demand-side focus (discovery). The market's unmet need is the force that pulls a company and its product into existence, not the other way around.